Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics
Diabetic Neuropathies
About this trial
This is an interventional treatment trial for Diabetic Neuropathies focused on measuring Synchronized Lifestyle Modification Program, Diabetic Neuropathy, Oral Hypoglycemic Agents
Eligibility Criteria
Inclusion Criteria:
- Gender includes both male and female
- Patients between age group 40-75 years
- Clinically diagnosed patients of Type 2 diabetes on OHAs and GLP-1 analogues
- Diabetic patients with symptomatic peripheral neuropathy (Severity of DPN is associated with a physical examination score > 2.5 by using Michigan Neuropathy Screening Instrument (MNSI) with grades mild, moderate and severe)
Exclusion Criteria:
- Type 1 diabetic patients
- Age < 40 years and > 75 years
- Patients with any other co-morbidities (Heart, liver and kidney diseases)
- Patients with neuropathies due to any other disease
- Orthopaedic and surgical procedure of lower limbs
- Patients with foot ulcers
- Peripheral vascular diseases
- Patients receiving any structured supervised physiotherapy
- Pregnant females
Sites / Locations
- Pakistan Railway HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Synchronized Lifestyle Modification Program (SLP)
Synchronized Lifestyle Modification Program along with Physiotherapy
Physiotherapy
Control Group
Synchronized Lifestyle Modification Program ( Synchronization of dietary intake with the natural circadian rhythm of the body)
Synchronized Lifestyle Modification Program along with Physiotherapy (Synchronization of dietary intake and Physiotherapy including aerobic, resistance, flexibility and balance exercises)
Physiotherapy (aerobics, resistance, flexibility and balance exercises)
No Intervention will be given to this group ( conventional medicine will be given to these patient )